-
-
The Centers for Disease Control and Preventions (CDC) Advisory Committee on Immunization Practices (ACIP) has released its revised recommendations for the prevention and control of influenza.
-
In April 2002, Donna Zazworsky, MS, RN, CCM, FAAN, director of grants, partnerships, and policy at St. Elizabeth of Hungary Clinic in Tucson, AZ, got a telephone call from a case manager at a local hospital who wanted to know if the clinic had a hospital bed it could donate for use by a 17-year-old patient who was being discharged.
-
The trauma team at Borgess Medical Center in Kalamazoo, MI, refers to Dorothy Malcolm, RN, BSN, as the glue that holds us all together. As trauma case manager, Malcolm coordinates care for trauma patients from the time they come into the emergency department (ED), during their entire stay in the hospital and while they are being treated in the outpatient follow-up clinics.
-
Merging the case management department with the quality department is the best thing weve ever done, says Sharon Simmons, CRNP, MSN, CNOR, director of clinical excellence for St. Vincents Hospital in Birmingham, AL. Combining the departments has resulted in a tremendous improvement in quality of care as well as improved outcomes, she adds.
-
-
Privately held Concentric Medical (Mountain View, California) received clearance from the FDA in mid-August to market the Merci Retriever, the first medical device cleared by that agency to remove blood clots from the brain in patients experiencing an ischemic stroke.
-
Douglas Smith, PhD, has been promoted from director of engineering to vice president of engineering for CardiacAssist (Pittsburgh, Pennsylvania). Max Klix-Saravia, formerly controller of the company, was promoted to vice president of finance. The former CFO position was vacated by F. Thomas Casey, who retired.
-
Alere Medical (Reno, Nevada) said it would provide its comprehensive heart failure management program to Humanas (Louisville, Kentucky) Medicare Advantage members who suffer from advanced congestive heart failure.
-
Angiotech Pharmaceuticals (Vancouver, British Columbia), the provider of drug coatings for stents and other medical devices, closed its acquisition of NeuColl (Los Gatos, California) in an all-cash transaction of nearly $13 million. Previously, Angiotech had obtained an equity interest in NeuColl through the acquisition of Cohesion Technologies in January 2003.
